Cargando…

SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis

Detalles Bibliográficos
Autores principales:	Liao, Shu-Yi, Gerber, Anthony N., Zelarney, Pearlanne, Make, Barry, Wechsler, Michael E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716899/ https://www.ncbi.nlm.nih.gov/pubmed/35549647 http://dx.doi.org/10.1164/rccm.202203-0599LE

Ejemplares similares

Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical Conditions: A Real-World Analysis
por: Liao, Shu-Yi, et al.
Publicado: (2022)

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines
por: Westreich, Aaron, et al.
Publicado: (2023)

Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients
por: Liu, Haolin, et al.
Publicado: (2023)

Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients
por: Liu, Haolin, et al.
Publicado: (2023)

Reply to Liao et al.: SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis
por: Runnstrom, Martin C., et al.
Publicado: (2022)

Characteristics and outcomes of ambulatory patients with suspected COVID-19 at a respiratory referral center
por: Guntur, Vamsi P., et al.
Publicado: (2022)

Improvement in Stage of Lung Cancer Diagnosis With Incidental Pulmonary Nodules Followed With a Patient Tracking System and Computerized Registry
por: Carr, Laurie L., et al.
Publicado: (2022)

Need for longitudinal studies to assess the real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma
por: Kamat, Siddhesh, et al.
Publicado: (2022)

Identifying “Real” Patients in the Real World
por: Callahan, Sean J.
Publicado: (2020)

Need for longitudinal studies to assess the real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma – Authors´ reply
por: Fritzsching, Benedikt, et al.
Publicado: (2022)

Real world and hyper reality
por: Gautret, Philippe, et al.
Publicado: (2021)

Reply to Callahan: Identifying “Real” Patients in the Real World
por: Dempsey, Timothy M.
Publicado: (2020)

Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics
por: Kagohashi, Katsunori, et al.
Publicado: (2022)

Selection of Biologics for Type 2–High Asthma
por: Yilmaz, Insu
Publicado: (2019)

Correspondence on Body Weight, Anti-SARS-CoV-2 Antibody and mRNA Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis
por: Raghunandan, Sharmila, et al.
Publicado: (2023)

Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine
por: Bradley, Todd, et al.
Publicado: (2021)

Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccination
por: Frey, Sarah, et al.
Publicado: (2021)

Reply to Yilmaz: Selection of Biologics for Type 2–High Asthma
por: McGregor, Mary Clare, et al.
Publicado: (2019)

Aripiprazole in the treatment of acute episode of schizophrenia: a real-world study in China
por: Li, Qian, et al.
Publicado: (2023)

Real-world clinical experience of secukinumab in Chinese patients with psoriasis in real-world practice: a 36-week single-center study of 24 patients
por: Zhang, Jing, et al.
Publicado: (2020)

Supraglottitis as the sole manifestation of COVID-19 in a patient who received two doses of mRNA vaccine
por: Chang, Kai-Ming, et al.
Publicado: (2022)

Artificial intelligence for malaria: Bridging the gap for real world usage
por: FAN, Bingwen Eugene, et al.
Publicado: (2022)

Maribavir for Cytomegalovirus Treatment in the Real World—Not a Silver Bullet
por: Fung, Monica, et al.
Publicado: (2022)

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
por: Krammer, Florian, et al.
Publicado: (2021)

Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease
por: Al‐Janabi, A., et al.
Publicado: (2021)

Biologics in severe asthma: the role of real-world evidence from registries
por: Paoletti, Giovanni, et al.
Publicado: (2022)

Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma
por: Runnstrom, Martin C., et al.
Publicado: (2022)

Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies
por: Deng, Zhenan, et al.
Publicado: (2023)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Real-world impact of the COVID-19 pandemic on the assessment of anaesthesiology residents
por: Kealey, Alayne, et al.
Publicado: (2020)

Medication adherence in Fabry patients treated with migalastat: Real world experience
por: Riccio, Eleonora, et al.
Publicado: (2023)

Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2013)

Healthcare Resource Utilization in Patients Receiving Omalizumab for Allergic Asthma in a Real-World Setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2014)

I feel you-monitoring environmental variables related to asthma in an integrated real-time frame
por: Berenguer, Anabela Gonçalves
Publicado: (2015)

Real-world renal function among patients with multiple myeloma in the United States
por: Mikhael, Joseph, et al.
Publicado: (2021)

Real world clinical performance of SARS-CoV-2 rapid antigen tests in suspected COVID-19 cases in Taiwan
por: Tsai, Shao-Chen, et al.
Publicado: (2021)

Real-world benefits of biologics for asthma: Exacerbation events and systemic corticosteroid use
por: Kimura, Yuya, et al.
Publicado: (2021)

Clinically meaningful benefit: real world use compared against the American and European guidelines
por: Dreicer, Jessica J., et al.
Publicado: (2017)

Real-world investigation of the efficacy and safety of secukinumab for psoriasis treatment in a Chinese population
por: Zeng, Jing-Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m023l231n07nbl0ugksdoahsk8